GlassScriptPhysician profile
Rachel A Carr
NPI 1588894869
$1,955.90
in general payments reported to CMS, 2019-2025
26 companies · $491 in 2025
The $491 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $54.95 · 2021: $13.60 · 2022: $322 · 2023: $419 · 2024: $341 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $269.64 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $239.46 | 2020-2025 | Acessa Provu System, Omni Hysteroscope, Fluent Fluid Management System |
| Pfizer INC. | $238.63 | 2019-2025 | |
| Abbvie INC. | $224.39 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $195.44 | 2019-2025 | |
| Biogen, INC. | $97.07 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $93.30 | 2024-2025 | Myfembree |
| Organon LLC | $80.49 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $74.13 | 2022-2023 | Slynd |
| Minerva Surgical, INC | $64.01 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $56.26 | 2022-2023 | Exparel |
| Mayne Pharma Commercial LLC | $46.27 | 2023 | |
| Millicent US INC | $36.66 | 2024-2025 | Intrarosa, Femlyv |
| Avanos Medical | $35.98 | 2019 | |
| Merck Sharp & Dohme LLC | $29.37 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24.65 | 2025 | Dexcom G6 Transmitter |
| Covidien LP | $19.39 | 2019 | |
| Abbott Laboratories | $18.91 | 2022 | |
| Daiichi Sankyo INC. | $18.44 | 2019 | |
| Ethicon US, LLC | $16.84 | 2019 | |
| Inari Medical, INC. | $16.69 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Myovant Sciences INC. | $14.46 | 2022 | |
| Duchesnay USA Incorporated | $14.44 | 2019 | |
| Optumhealth Care Solutions, LLC | $13.50 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Kerecis Limited | $12.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Meditrina | $5.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.